Page last updated: 2024-09-03

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and triazoles

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with triazoles in 1 studies

Compound Research Comparison

Studies
(n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime)
Trials
(n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime)
Recent Studies (post-2010)
(n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime)
Studies
(triazoles)
Trials
(triazoles)
Recent Studies (post-2010) (triazoles)
8803625,8082,25213,501

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, L; Li, J; Li, T; Li, Z; Lin, L; Wang, P; Xu, Y; Zhang, Y; Zhao, W1

Other Studies

1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and triazoles

ArticleYear
Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Biochemistry. Biokhimiia, 2012, Volume: 77, Issue:2

    Topics: Acetylglucosamine; Apoptosis; beta-N-Acetylhexosaminidases; Binding Sites; Caspase 3; Catalytic Domain; Enzyme Inhibitors; Hexosaminidase A; Hexosaminidase B; Humans; Kinetics; Oximes; Phenylcarbamates; Protein Isoforms; Recombinant Proteins; Substrate Specificity; Triazoles

2012